Journals / Selçuk Tıp Dergisi / 2009 / Cilt: 25 - Sayı: 4

A gastric obstruction during the multi-dose activated charcoal treatment

Tekrarlayan dozlarda aktif kömür tedavisi sırasında gelişen gastrik obstrüksiyon

Pages
219–222
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case it is important to being aware of this complication and managing it in the appropirate time.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, it was aimed to rise a notice of gastric obstruction, a rare complication of multi-dose activated charcoal treatment of organophosphate poisoning, because of a case.
📊
Key Findings & Data:Clinical signs that thought to be an intestinal obstruction was recognized in a 65 aged male patient who was treated with multi-dose activated charcoal because of organophosphate poisoning.
💡
Conclusion & Impact:In this case it is important to being aware of this complication and managing it in the appropirate time.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study, it was aimed to rise a notice of gastric obstruction, a rare complication of multi-dose activated charcoal treatment of organophosphate poisoning, because of a case. Clinical signs that thought to be an intestinal obstruction was recognized in a 65 aged male patient who was treated with multi-dose activated charcoal because of organophosphate poisoning. Some solid images could be related to activated charcoal determined by the computerized tomography. These congromelates were emptied by endoscopy since the gastric lavage was insufficient. A gastrointestinal obstruction may develope during the multi-dose activated charcoal treatment. In this case it is important to being aware of this complication and managing it in the appropirate time.

Özet

Bu çalışmada, organofosfat zehirlenmesi olgusu nedeni ile tekrarlayan dozlarda aktif kömür uygulanmasının nadir bir komplikasyonu olan gastrik obstrüksiyona dikkat çekilmesi amaçlandı. 65 yaşında organofosfat zehirlenmesi nedeni ile tekrarlayan aktif kömür tedavisi uygulanan erkek hastada, tedavinin ikinci günü intestinal obstrüksiyon düşündüren klinik bulgular gözlendi. Bilgisayarlı tomografi ile değerlendirilen hastanın midesinde solid oluşumlar tespit edildi. Bunların aktif kömüre ait olabileceği düşünüldü. Gastrik lavaj ile aktif kömür birikintisi boşaltılamayınca endoskopik girişim ile bu oluşumlar temizlendi. tekrarlayan dozlarda aktif kömür tedavisi sırasında gastrointestinal obstruksiyon gelişebilir. Bu durumda dikkatli olmak ve zamanında müdahale etmek önemlidir.

🔖

Cite This Article

ÇELİK, J. B., YOSUNKAYA, A., REİSLİ, R., KARA, İ., OTELCİOĞLU, Ş. (2009). A gastric obstruction during the multi-dose activated charcoal treatment. Selçuk Tıp Dergisi, Cilt: 25 - Sayı: 4, 219–222. https://ajindex.com/articles/319171

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. WHO in collaboration with UNEP. Public health impact of pesticides used in agriculture. Geneva: World Health Organization, 1990 2. Robey WC, Meggs WJ. Insecticides, Herbicides and Rodenticides. In: Tintinalli JE, Kelen GD, Stapczynski JS, eds. Emergency Medicine: a Comprehensive Study Guide. 6th Edn. McGraw-Hill Co, New York, 2004; pp. 1134-43. 3. Maura LS, Nawarskas JJ, Mauro VF. Misadventures with activated charcoal and recommendations for safe use. Ann Pharmacother 1994; 28: 915-24 4 Sarıtaş A, Çakır Z, Aslan Ş. Organofosfat ve Karbamat Zehirlenmeleri. The Euroasian j Med 2007; 39: 55-9 5. Bond GR. The role of activated charcoal and gastric emptying in gastrointestinal decontamination: a state-of-the-art review. Ann Emerg Med 2002; 39: 273-86 6. Watson WA. Factors influencing the clinical efficacy of activated charcoal. Drug Intel Clin Pharm 1987;21: 160- 6. 7. Dorrington CL, Johnson DW, Brant R. The frequency of complications associated with the use of multiple-dose activated charcoal. Ann Emerg Med 2003;41: 370- 7 8. Moll J, Kerns W, Tomaszewski C, Rose R. Incidence of aspiration pneumonia in intubated patients receiving activated charcoal. J Emerg Med 1999;17: 279- 83. 9. Watson WA, Cremer KF, Chapman JA. Gastrointestinal obstruction associated with multiple-dose activated charcoal. J Emerg Med 1986;4:401-7 10. Chan JC, Saranasuriya C, Waxman BP. Bezoar causing small bowel obstruction after repeated activated charcoal administration. Med J Aust 2005;183:537. 11. Kimura Y, Kamada Y, Kimura S. Efficacy of abdominal computed tomography and nasogastric tube in acute poisoning patients. Am J Emerg Med 2008;26:738. 12. Schwerk C, Schulz M, Schwerk N, Blüher S, Kiess W, Siekmeyer W. Etilefrinhydrochloride tablet ingestion: successful therapy by endoscopic removal of tablet conglomerate. Klin Padiatr 2009;221:93-6.